NYSE · CIK 0001773751
HIMS Hims & Hers Health, Inc.
Insider trading from SEC Form 4. Last filing 10 d ago. Close $30.92 on Oct 9, 2026, +113% from the 52-week low and -51% from the high.
Last 90 days
Net insider value
-$2.3M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
8
$2.3M by 4 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
HIMSOct 9, 2026 · close 30.92
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Hims & Hers Health, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Soleil Boughton Chief Legal Officer sell | $101k 3,461 shares | -1% | +105% from low-53% from high | |
| 17Weak | Oluyemi Okupe Chief Financial Officer sell | $59k 2,000 shares | -1% | +102% from low-53% from high | |
| 30Weak | Oluyemi Okupe Chief Financial Officer sell | $877k 29,277 shares | -11% | +110% from low-52% from high | |
| 32Weak | Oluyemi Okupe Chief Financial Officer sell | $355k 12,313 shares | -5% | +92% from low-56% from high | |
| 21Weak | Soleil Boughton Chief Legal Officer sell | $174k 6,236 shares | -2% | +93% from low-55% from high | |
| 31Weak | Michael Chi Chief Operating Officer sell | $398k 14,027 shares | -3% | - | |
| 23Weak | Mohamed Elshenawy CTO sell | $226k 7,954 shares | -4% | - | |
| 20Weak | Soleil Boughton Chief Legal Officer sell | $98k 3,458 shares | -1% | - | |
| 33Weak | Irene Becklund PAO sell | $507k 8,485 shares | -92% | +288% from low-14% from high | |
| 12Weak | Soleil Boughton Chief Legal Officer sell | $463k 8,023 shares | -5% | +291% from low-13% from high | |
| 20Weak | Michael Chi Chief Commercial Officer sell | $1.0M 17,102 shares | -6% | +288% from low-14% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $14M 240,771 shares | -148% | +291% from low-13% from high | |
| 9Weak | Michael Chi Chief Commercial Officer sell | $319k 5,600 shares | -2% | +262% from low-20% from high | |
| 9Weak | Michael Chi Chief Commercial Officer sell | $286k 5,100 shares | -2% | +269% from low-18% from high | |
| 22Weak | Soleil Boughton Chief Legal Officer sell | $181k 3,233 shares | -2% | +249% from low-22% from high | |
| 43Moderate | Irene Becklund PAO sell | $271k 5,071 shares | -100% | +250% from low-22% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $10M 175,661 shares | -191% | +323% from low-6% from high | |
| 25Weak | Melissa Baird Chief Operating Officer sell | $1.9M 33,333 shares | -4% | +262% from low-20% from high | |
| 22Weak | Soleil Boughton Chief Legal Officer sell | $181k 3,235 shares | -2% | +262% from low-20% from high | |
| 20Weak | Soleil Boughton Chief Legal Officer sell | $98k 3,236 shares | -2% | +87% from low-59% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $3.1M 91,667 shares | -69% | +87% from low-59% from high | |
| 23Weak | Melissa Baird Chief Operating Officer sell | $859k 33,333 shares | -4% | +69% from low-62% from high | |
| 29Weak | Irene Becklund PAO sell | $78k 2,936 shares | -37% | +66% from low-63% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $2.4M 83,994 shares | -65% | +76% from low-61% from high | |
| 24Weak | Soleil Boughton Chief Legal Officer sell | $280k 7,387 shares | -4% | +166% from low-41% from high | |
| 24Weak | Melissa Baird Chief Operating Officer sell | $911k 33,337 shares | -4% | +93% from low-57% from high | |
| 23Weak | Irene Becklund PAO sell | $63k 2,203 shares | -22% | +83% from low-59% from high | |
| 19Weak | Soleil Boughton Chief Legal Officer sell | $90k 3,236 shares | -2% | +94% from low-57% from high | |
| 25Weak | Melissa Baird Chief Operating Officer sell | $2.4M 67,687 shares | -8% | +118% from low-51% from high | |
| 43Moderate | Oluyemi Okupe Chief Financial Officer sell | $749k 23,118 shares | -15% | +128% from low-49% from high | |
| 19Weak | Irene Becklund PAO sell | $284k 8,277 shares | -45% | +106% from low-54% from high | |
| 5Weak | Soleil Boughton Chief Legal Officer sell | $111k 3,236 shares | -2% | +106% from low-54% from high | |
| 17Weak | Patrick Harrison Carroll Chief Medical Officer sell | $799k 23,287 shares | -10% | +106% from low-54% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $8.6M 254,421 shares | -132% | +127% from low-50% from high | |
| 38Weak | Irene Becklund PAO sell | $77k 2,203 shares | -50% | +127% from low-50% from high | |
| 68Notable | Christiane Pendarvis director sell | $500k 12,500 shares | -52% | +168% from low-41% from high | |
| 31Weak | Irene Becklund PAO sell | $131k 2,913 shares | -40% | +166% from low-41% from high | |
| 18Weak | Michael Chi Chief Commercial Officer sell | $833k 17,303 shares | -8% | +236% from low-25% from high | |
| 23Weak | Soleil Boughton Chief Legal Officer sell | $252k 4,152 shares | -3% | +283% from low-3% from high | |
| 12Weak | Michael Chi Chief Commercial Officer sell | $444k 7,500 shares | -4% | +350% from low0% from high | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $10M 175,661 shares | -175% | +283% from low-3% from high | |
| 25Weak | Melissa Baird Chief Operating Officer sell | $3.0M 67,687 shares | -9% | - | |
| 9Weak | Michael Chi Chief Commercial Officer sell | $314k 7,259 shares | -4% | - | |
| 20Weak | Oluyemi Okupe Chief Financial Officer sell | $498k 11,581 shares | -10% | - | |
| 19Weak | Oluyemi Okupe Chief Financial Officer sell | $451k 11,581 shares | -9% | - | |
| 21Weak | Soleil Boughton Chief Legal Officer sell | $147k 4,153 shares | -3% | - | |
| 3Weak | Michael Chi Chief Commercial Officer sell | $73k 2,054 shares | -1% | - | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $3.5M 100,000 shares | -78% | - | |
| 14Weak | Michael Chi Chief Commercial Officer sell | $536k 17,304 shares | -8% | - | |
| 37Weak | Andrew Dudum Chief Executive Officer sell | $815k 27,098 shares | -49% | - | |
| 25Weak | Melissa Baird Chief Operating Officer sell | $2.0M 67,687 shares | -9% | - | |
| 25Weak | Soleil Boughton Chief Legal Officer sell | $1.6M 54,153 shares | -25% | - | |
| 0Weak | Michael Chi Chief Commercial Officer sell | $8,776 306 shares | -0% | - | |
| 42Moderate | Andrew Dudum Chief Executive Officer sell | $438k 14,569 shares | -52% | - | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $2.3M 83,994 shares | -130% | - | |
| 6Weak | Michael Chi Chief Commercial Officer sell | $175k 7,259 shares | -4% | - | |
| 16Weak | Oluyemi Okupe Chief Financial Officer sell | $283k 11,581 shares | -9% | - | |
| 40Moderate | Soleil Boughton Chief Legal Officer sell | $7.5M 268,932 shares | -61% | - | |
| 2Weak | Michael Chi Chief Commercial Officer sell | $51k 2,055 shares | -1% | - | |
| 16Weak | Oluyemi Okupe Chief Financial Officer sell | $286k 11,581 shares | -9% | - | |
| 13Weak | Michael Chi Chief Commercial Officer sell | $484k 17,303 shares | -8% | - | |
| 28Weak | Oluyemi Okupe Chief Financial Officer sell | $126k 4,213 shares | -3% | - | |
| 7Weak | Michael Chi Chief Commercial Officer sell | $195k 7,500 shares | -4% | - | |
| 40Moderate | Oluyemi Okupe Chief Financial Officer sell | $489k 18,959 shares | -13% | - | |
| 30Weak | Irene Becklund PAO sell | $336k 10,484 shares | -59% | - | |
| 23Weak | Michael Chi Chief Commercial Officer sell | $823k 25,550 shares | -12% | - | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $6.2M 204,907 shares | -182% | - | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $6.2M 204,907 shares | -182% | - | |
| 30Weak | Melissa Baird Chief Operating Officer sell | $2.7M 85,561 shares | -12% | - | |
| 8Weak | Michael Chi Chief Commercial Officer sell | $234k 7,259 shares | -4% | - | |
| 3Weak | Michael Chi Chief Commercial Officer sell | $69k 2,054 shares | -1% | - | |
| 65Notable | Andrew Dudum Chief Executive Officer sell | $1.1M 33,513 shares | -50% | - | |
| 18Weak | Soleil Boughton Chief Legal Officer sell | $70k 2,343 shares | -1% | - | |
| 12Weak | Michael Chi Chief Commercial Officer sell | $458k 17,303 shares | -9% | - | |
| 37Weak | Oluyemi Okupe Chief Financial Officer sell | $3.0M 101,993 shares | -49% | - | |
| 25Weak | Melissa Baird Chief Operating Officer sell | $1.2M 58,750 shares | -9% | - | |
| 0Weak | Irene Becklund PAO sell | $9,166 472 shares | -8% | - | |
| 6Weak | Michael Chi Chief Commercial Officer sell | $165k 7,500 shares | -4% | - | |
| 60Notable | David B Wells director sell | $1.2M 40,000 shares | -20% | - | |
| 47Moderate | Oluyemi Okupe Chief Financial Officer sell | $4.3M 142,886 shares | -56% | - | |
| 34Weak | Anja Manuel director buy | $132k 5,000 shares | - | - | |
| 17Weak | Soleil Boughton Chief Legal Officer sell | $62k 2,338 shares | -1% | - | |
| 41Moderate | Patrick Harrison Carroll Chief Medical Officer sell | $133k 4,707 shares | -2% | - | |
| 7Weak | Michael Chi Chief Commercial Officer sell | $180k 7,259 shares | -4% | - | |
| 45Moderate | Patrick Harrison Carroll Chief Medical Officer sell | $331k 15,000 shares | -7% | - | |
| 1Weak | Michael Chi Chief Commercial Officer sell | $45k 2,054 shares | -1% | - | |
| 50Moderate | Andrew Dudum Chief Executive Officer sell | $6.9M 333,332 shares | -51% | - | |
| 17Weak | Soleil Boughton Chief Legal Officer sell | $54k 2,339 shares | -1% | - | |
| 11Weak | Michael Chi Chief Commercial Officer sell | $381k 17,304 shares | -8% | - | |
| 6Weak | Michael Chi Chief Commercial Officer sell | $167k 7,500 shares | -4% | - | |
| 0Weak | Irene Becklund PAO sell | $11k 471 shares | -8% | - | |
| 17Weak | Soleil Boughton Chief Legal Officer sell | $48k 2,339 shares | -1% | - | |
| 30Weak | Michael Chi Chief Commercial Officer sell | $1.7M 75,493 shares | -28% | - | |
| 47Moderate | Oluyemi Okupe Chief Financial Officer sell | $5.5M 269,739 shares | -65% | - |
Congressional trades
1 trade in HIMS disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Purchase | HIMS Hims & Hers Health, Inc. Class A Common Stock | $1,001 to $15k | Aug 4, 2025 / Sep 12, 2025 39 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oluyemi Okupe Chief Financial Officer | SOpen-market sale Class A Common Stock10b5-1 | -2,000 | $29.70 | $59k | 234,527 | 10 d ago |
| Sep 30, 2026 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,461 | $29.17 | $101k | 300,809 | 10 d ago |
| Sep 22, 2026 | Oluyemi Okupe Chief Financial Officer | MOption exercise Class A Common Stock10b5-1 | +14,000 | $5.01 | $70k | 265,804 | 19 d ago |
| Sep 22, 2026 | Oluyemi Okupe Chief Financial Officer | SOpen-market sale Class A Common Stock10b5-1 | -29,277 | $29.95 | $877k | 236,527 | 19 d ago |
| Sep 22, 2026 | Oluyemi Okupe Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -14,000 | $0.00 | $0 | 66,872 | 19 d ago |
| Sep 17, 2026 | Oluyemi Okupe Chief Financial Officer | SOpen-market sale Class A Common Stock10b5-1 | -12,313 | $28.82 | $355k | 251,804 | 24 d ago |
| Sep 15, 2026 | Mohamed Elshenawy CTO | SOpen-market sale Class A Common Stock10b5-1 | -7,954 | $28.39 | $226k | 185,556 | 25 d ago |
| Sep 16, 2026 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -6,236 | $27.86 | $174k | 304,270 | 25 d ago |
| Sep 15, 2026 | Michael Chi Chief Operating Officer | SOpen-market sale Class A Common Stock10b5-1 | -14,027 | $28.39 | $398k | 456,660 | 25 d ago |
| Sep 2, 2026 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,458 | $28.33 | $98k | 310,506 | 39 d ago |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | MOption exercise Class A Common Stock10b5-1 | +41,420 | - | - | 194,614 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Class A Common Stock10b5-1 | +87,106 | - | - | 343,486 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Class A Common Stock10b5-1 | +17,984 | - | - | 17,984 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +164,368 | - | - | 253,679 | Jun 17, 2025 |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | FTax withholding Class A Common Stock10b5-1 | -23,282 | $55.48 | $1.3M | 171,332 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | FTax withholding Class A Common Stock10b5-1 | -48,166 | $55.48 | $2.7M | 295,756 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | FTax withholding Class A Common Stock10b5-1 | -90,672 | $55.48 | $5.0M | 163,007 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | FTax withholding Class A Common Stock10b5-1 | -8,787 | $55.48 | $488k | 9,197 | Jun 17, 2025 |
| Jun 16, 2025 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -5,451 | $56.80 | $310k | 165,881 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -2,792 | $56.35 | $157k | 160,215 | Jun 17, 2025 |
| Jun 17, 2025 | Irene Becklund PAO | SOpen-market sale Class A Common Stock10b5-1 | -8,485 | $59.75 | $507k | 712 | Jun 17, 2025 |
| Jun 17, 2025 | Michael Chi Chief Commercial Officer | SOpen-market sale Class A Common Stock10b5-1 | -17,102 | $59.75 | $1.0M | 278,654 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,871 | $0.00 | $0 | 5,614 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -40,120 | $56.44 | $2.3M | 245,074 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -9,356 | $0.00 | $0 | 28,069 | Jun 17, 2025 |
| Jun 17, 2025 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -2,572 | $59.75 | $154k | 163,309 | Jun 17, 2025 |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -10,916 | $0.00 | $0 | 32,747 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -7,414 | $56.90 | $422k | 237,660 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -16,496 | $0.00 | $0 | 82,478 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,019 | $0.00 | $0 | 12,058 | Jun 17, 2025 |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -12,223 | $0.00 | $0 | 85,561 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,291 | $0.00 | $0 | 9,164 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +108,334 | $2.43 | $263k | 268,549 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -16,297 | $0.00 | $0 | 114,081 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,066 | $0.00 | $0 | 28,462 | Jun 17, 2025 |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -12,099 | $0.00 | $0 | 133,089 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +17,001 | $2.43 | $41k | 285,550 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -19,358 | $0.00 | $0 | 212,943 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -4,345 | $0.00 | $0 | 47,794 | Jun 17, 2025 |
| Jun 13, 2025 | Soleil Boughton Chief Legal Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -6,182 | $0.00 | $0 | 92,743 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -17,001 | $58.61 | $996k | 268,549 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -10,599 | $0.00 | $0 | 158,988 | Jun 17, 2025 |
| Jun 13, 2025 | Irene Becklund PAO | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,392 | $0.00 | $0 | 20,892 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -90,624 | $56.39 | $5.1M | 177,925 | Jun 17, 2025 |
| Jun 13, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -17,710 | $56.92 | $1.0M | 160,215 | Jun 17, 2025 |
| Jun 17, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -15,945 | $58.50 | $933k | 144,270 | Jun 17, 2025 |
| Jun 17, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -49,165 | $59.45 | $2.9M | 95,105 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -35,242 | $0.00 | $0 | 105,726 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -35,446 | $0.00 | $0 | 248,126 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -74,530 | $0.00 | $0 | 819,828 | Jun 17, 2025 |
| Jun 13, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -19,150 | $0.00 | $0 | 287,256 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -108,334 | $0.00 | $0 | 864,731 | Jun 17, 2025 |
| Jun 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -17,001 | $0.00 | $0 | 85,009 | Jun 17, 2025 |
| Jun 12, 2025 | Delos M. Cosgrove director | MOption exercise Class A Common Stock | +9,935 | - | - | 64,339 | Jun 16, 2025 |
| Jun 12, 2025 | Deborah M. Autor director | MOption exercise Class A Common Stock | +6,175 | - | - | 6,175 | Jun 16, 2025 |
| Jun 12, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Class A Common Stock | +9,935 | - | - | 219,596 | Jun 16, 2025 |
| Jun 12, 2025 | Delos M. Cosgrove director | MOption exercise Restricted Stock Unitderivative | -9,935 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Class A Common Stock | +16,521 | - | - | 236,117 | Jun 16, 2025 |
| Jun 12, 2025 | Deborah M. Autor director | MOption exercise Restricted Stock Unitderivative | -6,175 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | Patrick Harrison Carroll Chief Medical Officer | FTax withholding Class A Common Stock | -6,177 | $55.48 | $343k | 229,940 | Jun 16, 2025 |
| Jun 13, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -3,533 | $0.00 | $0 | 52,996 | Jun 16, 2025 |
| Jun 13, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -4,839 | $0.00 | $0 | 53,236 | Jun 16, 2025 |
| Jun 12, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -9,935 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 13, 2025 | Patrick Harrison Carroll Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -8,149 | $0.00 | $0 | 48,892 | Jun 16, 2025 |
| Jun 10, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Class A Common Stock10b5-1 | +5,400 | $6.82 | $37k | 261,980 | Jun 11, 2025 |
| Jun 10, 2025 | Michael Chi Chief Commercial Officer | SOpen-market sale Class A Common Stock10b5-1 | -5,600 | $57.00 | $319k | 256,380 | Jun 11, 2025 |
| Jun 10, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,400 | $0.00 | $0 | 125,262 | Jun 11, 2025 |
| Jun 5, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Class A Common Stock10b5-1 | +28,776 | $13.90 | $400k | 256,580 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Class A Common Stock10b5-1 | +1,500 | $11.53 | $17k | 258,080 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | SOpen-market sale Class A Common Stock10b5-1 | -1,500 | $56.00 | $84k | 256,580 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Class A Common Stock10b5-1 | +3,600 | $13.90 | $50k | 260,180 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,600 | $56.00 | $202k | 256,580 | Jun 9, 2025 |
| Jun 5, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -28,776 | $0.00 | $0 | 15,000 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,600 | $0.00 | $0 | 11,400 | Jun 9, 2025 |
| Jun 6, 2025 | Michael Chi Chief Commercial Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,500 | $0.00 | $0 | 49,856 | Jun 9, 2025 |
| May 27, 2025 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,233 | $55.87 | $181k | 153,194 | May 29, 2025 |
| May 22, 2025 | Irene Becklund PAO | SOpen-market sale Class A Common Stock10b5-1 | -5,071 | $53.51 | $271k | 0 | May 27, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -2,792 | $59.27 | $165k | 89,311 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -25,307 | $57.86 | $1.5M | 307,421 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Dudum Family Community Property Trust10b5-1 | -22,227 | $58.70 | $1.3M | 285,194 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +17,001 | $2.43 | $41k | 106,312 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -17,001 | $58.72 | $998k | 89,311 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +108,334 | $2.43 | $263k | 197,645 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -49,265 | $57.84 | $2.8M | 148,380 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -52,642 | $58.67 | $3.1M | 95,738 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -6,427 | $59.21 | $381k | 89,311 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -17,001 | $0.00 | $0 | 102,010 | May 19, 2025 |
| May 16, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -108,334 | $0.00 | $0 | 973,065 | May 19, 2025 |
| May 12, 2025 | Mohamed Elshenawy Chief Technology Officer | AGrant or award Restricted Stock Unitderivative | +1,036,339 | $0.00 | $0 | 1,036,339 | May 14, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | MOption exercise Class A Common Stock10b5-1 | +33,333 | $2.43 | $81k | 838,416 | May 13, 2025 |
| May 12, 2025 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,235 | $56.00 | $181k | 156,427 | May 13, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | SOpen-market sale Class A Common Stock10b5-1 | -13,786 | $54.98 | $758k | 824,630 | May 13, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | SOpen-market sale Class A Common Stock10b5-1 | -6,801 | $55.86 | $380k | 817,829 | May 13, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | SOpen-market sale Class A Common Stock10b5-1 | -7,556 | $56.80 | $429k | 810,273 | May 13, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | SOpen-market sale Class A Common Stock10b5-1 | -5,190 | $57.87 | $300k | 805,083 | May 13, 2025 |
| May 12, 2025 | Melissa Baird Chief Operating Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -33,333 | $0.00 | $0 | 693,795 | May 13, 2025 |
| Apr 28, 2025 | Andrew Dudum Chief Executive Officer | MOption exercise Class A Common Stock10b5-1 | +41,667 | $2.43 | $101k | 133,770 | Apr 30, 2025 |
| Apr 28, 2025 | Soleil Boughton Chief Legal Officer | SOpen-market sale Class A Common Stock10b5-1 | -3,236 | $30.19 | $98k | 159,662 | Apr 30, 2025 |
| Apr 28, 2025 | Andrew Dudum Chief Executive Officer | SOpen-market sale Class A Common Stock10b5-1 | -41,667 | $30.19 | $1.3M | 92,103 | Apr 30, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Deborah M. Autordirector
- Melissa BairdChief Operating Officer
- Irene BecklundPAO
- Soleil BoughtonChief Legal Officer
- Patrick Harrison CarrollChief Medical Officer
- Michael ChiChief Commercial Officer
- Delos M. Cosgrovedirector
- Andrew DudumChief Executive Officer
- Mohamed ElshenawyChief Technology Officer
- Anja Manueldirector
- Oluyemi OkupeChief Financial Officer
- Christiane Pendarvisdirector
- David B Wellsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.